Heart failure & cardiomyopathiesCohort study

Clinical Impact of Diagnostic Delay by Red Flags Assessment in Transthyretin Amyloid Cardiomyopathy

JACC AdvPublished

  • retrospective
  • consecutive patients
  • 2 referral centers in Italy

Authors' conclusion

The median time from red-flag onset to ATTR-CM diagnosis is an independent predictor of all-cause and CV mortality. Enhancing early identification of noncardiac red flags across specialties may shorten the diagnostic pathway, facilitate earlier initiation of disease-modifying therapy, and ultimately improve clinical outcomes.

Study context

Population
Consecutive patients with transthyretin amyloid cardiomyopathy (ATTR-CM) from 2 referral centers in Italypatients included
Participants
208 patients
Exposure
Longer vs shorter median time from red-flag onset to diagnosis
Outcome
All-cause mortality

Main finding

As reported in the abstract

Adjusted hazard ratio

1.07

95% CI 1.01–1.14

P = 0.049

Longer vs shorter median time from red-flag onset to diagnosis
adjusted HR 1.07 (95% CI 1.01–1.14); P = 0.049

Observational data: associations, not effects.

Secondary outcomes

Cardiovascular (CV) mortality (secondary outcome)

Comparisonadjusted HR (95% CI)P value
longer median time from red-flag onset to diagnosis · higher risk with longer time; independently associated1.10 (1.02–1.18)P = 0.025

Cohort characteristics

median age
80 years
male
83.7%
wild-type transthyretin amyloidosis
96.6%

Timing of red flags

Red flags frequently emerged several years before diagnosis, with orthopedic and neurologic manifestations representing the earliest signals

Diagnostic pathways

cardiology referral
74.5%
  • diagnostic pathways were heterogeneous

Original publication

Clinical Impact of Diagnostic Delay by Red Flags Assessment in Transthyretin Amyloid Cardiomyopathy. JACC Adv. Published 2 September 2026. doi:10.1016/j.jacadv.2026.103200

Summarised from the published abstract; every number is checked against it